Monitoring
16 - 28 of
28 Results
Sort Results:
Article:
Aubagio (oh-BAH-gee-oh, teriflunomide), the third ORAL option for relapsing forms of multiple sclerosis (MS)
February 2014
Article:
the second ORAL drug for relapsing-remitting multiple sclerosis (MS), Tecfidera (TEK-fi-de-rah, dimethyl fumarate)
June 2013
Article:
risk of renal impairment in patients taking an ACE inhibitor or ARB, diuretic, and NSAID
December 2006